Puma Biotechnology, Inc.PBYINASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR+37.0%
5Y CAGR+61.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+37.0%/yr
vs +43.9%/yr prior
5Y CAGR
+61.1%/yr
Recent deceleration
Acceleration
-6.9pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
10.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 38.60% |
| Q3 2025 | 3.89% |
| Q2 2025 | 13.97% |
| Q1 2025 | -22.12% |
| Q4 2024 | -26.65% |
| Q3 2024 | 71.06% |
| Q2 2024 | 7.58% |
| Q1 2024 | -39.36% |
| Q4 2023 | 28.62% |
| Q3 2023 | 2.84% |
| Q2 2023 | 3.40% |
| Q1 2023 | -19.64% |
| Q4 2022 | 15.01% |
| Q3 2022 | -4.06% |
| Q2 2022 | 30.13% |
| Q1 2022 | -17.38% |
| Q4 2021 | 19.70% |
| Q3 2021 | -13.37% |
| Q2 2021 | -45.62% |
| Q1 2021 | 86.79% |
| Q4 2020 | 3.55% |
| Q3 2020 | -28.09% |
| Q2 2020 | 37.81% |
| Q1 2020 | -18.60% |
| Q4 2019 | 11.56% |
| Q3 2019 | 4.60% |
| Q2 2019 | -45.59% |
| Q1 2019 | 39.38% |
| Q4 2018 | 13.58% |
| Q3 2018 | 23.31% |
| Q2 2018 | -23.68% |
| Q1 2018 | 207.94% |
| Q4 2017 | 255.44% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |